Drugviu Revenue and Competitors
Estimated Revenue & Valuation
- Drugviu's estimated annual revenue is currently $1.5M per year.
- Drugviu's estimated revenue per employee is $87,000
Employee Data
- Drugviu has 17 Employees.
- Drugviu grew their employee count by 240% last year.
Drugviu Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $22.6M | 142 | -18% | N/A | N/A |
#2 | $41.3M | 259 | 44% | N/A | N/A |
#3 | $808.8M | 3984 | 9% | N/A | N/A |
#4 | $1320M | 1901 | 8% | $445M | N/A |
#5 | $513.8M | 2478 | 11% | $215M | N/A |
#6 | $16.7M | 115 | 4% | N/A | N/A |
#7 | $469.4M | 2264 | 8% | $298.8M | N/A |
#8 | $84.3M | 465 | 33% | N/A | N/A |
#9 | $19.4M | 127 | -2% | $46.6M | N/A |
#10 | $81.2M | 448 | 25% | N/A | N/A |
What Is Drugviu?
Drugviu is on a mission to improve the life of people with Autoimmune Diseases. Our comprehensive Real World Evidence (RWE) and Patient Reported Outcomes (PRO) platform generates the world's most complete and diverse clinical grade data for immunological research. Our platform is used to advance research and drug development for autoimmune diseases. We partner with academic research institutions, clinicians, laboratories, and biopharmaceutical companies to accelerate new treatments and advance research.
keywords:N/A
N/A
Total Funding
17
Number of Employees
$1.5M
Revenue (est)
240%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Drugviu News
In addition, finalists Boddle Learning and DrugViu received investments of $100,000 each. Additional funding from angel investors and...
In addition, finalists Boddle Learning and DrugViu received investments of $100,000 each. Additional funding from angel investors and...
Previous challenge winners include DrugViu, which aims to create greater health equity for people of color, and Bioo, a company that creates...
Other Companies in New York City Area
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $18.8M | 92 | -21% | N/A |
#2 | $57.4M | 234 | 0% | $1.4M |